Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Change in Management

 It is hereby informed you that, based on recommendation of the Nomination and Remuneration Committee of the Board, the Board of Directors of Novartis India Limited ('Company') at their meeting held today, have approved the appointment of Mr. Sanjay Murdeshwar as Vice Chairman & Managing Director of the Company effective June 15, 2019, subject to the approval of Shareholders and Central Government, if any. A brief profile of Mr. Sanjay Murdeshwar is enclosed for your information. The said meeting of the Board of Directors commenced at 11:30 am and concluded at 12:30 pm. Please take the above intimation on record.
15-06-2019
Bigul

Novartis' $2-mn therapy for rare disorder is world's most expensive drug

 Novartis executives defended the price, saying that a one-time treatment is more valuable than expensive long-term treatments
25-05-2019
Bigul

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Notice to Shareholders: Transfer of Equity Shares to Investor Education and Protection Fund Suspense Account Dear Sirs, Please find enclosed copies of notice for the attention of equity shareholders of the Company in respect of transfer of equity shares to Investor Education and Protection Fund (IEPF) Suspense Account published on May 25, 2019 in the Financial Express and Navshakti in accordance with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016. Thanking you
25-05-2019
Bigul

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sirs, In continuation to our letter dated May 23, 2019 please find enclosed copies of Audited Financial Results of the Company for the Fourth quarter and Year ended March 31, 2019 that was published in the Financial Express and Navshakti on May 24, 2019. The same has been made available on the website of the Company www.novartis.in. Thanking you
24-05-2019
Bigul

NOVARTIS INDIA LTD. - 500672 - Fixes Book Closure for Final Dividend & AGM

 Novartis India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 02, 2019 to August 09, 2019 (both days inclusive) for the purpose of Payment of Final Dividend & 71st Annual General Meeting (AGM) of the Company to be held on August 09, 2019.
24-05-2019
Bigul

Novartis India Ltd - 500672 - Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report21/05/2019 3 Name of the Certifying Firm Saraf & Associates 4 Name of the Certifying Individual K.G. Saraf 5Membership TypeFCS 6 Membership Number 1596 7 CP No. 642 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO
23-05-2019
Bigul

Novartis India Ltd - 500672 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNOVARTIS INDIA LTD. 2CINL24200MH1947PLC006104 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Trivikram Guda Designation: Company Secretary & Compliance Officer EmailId: trivikram.guda@novartis.com Name of the Chief Financial Officer: Monaz Noble Designation: Whole Time Director and Chief Financial Officer EmailId: monaz.noble@novartis.com Date: 23/05/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
23-05-2019
Bigul

NOVARTIS INDIA LTD. - 500672 - Board recommends Final Dividend (AGM on August 09, 2019)

 Novartis India Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 23, 2019, inter alia, has recommended final dividend of Rs. 10/- per equity share of Rs. 5/- each for the year ended March 31, 2019.
23-05-2019
Bigul

Novartis India Ltd - 500672 - Financial Results 31. March 31,2019

 1. Audited Financial Results of the Company for the quarter and year ended March 31, 2019. Copy of the financial results approved at this meeting along with the Limited Review Report provided by Deloitte Haskins & Sells LLP, Auditors of the Company is enclosed as Annexure 1. We have made arrangements for publishing an extract of the approved financial results as per the format prescribed under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, in the selected newspapers. 2. Recommendation of final dividend of Rs 10/- per equity share of Rs 5/- each for the year ended March 31, 2019; 3. Date for convening the 71st Annual General Meeting of shareholders of the Company is scheduled to be held on Friday, August 09, 2019 at 11.30 a.m.; 4. Closure of the Register of Members and Share Transfer books from Friday, August 2, 2019 to Friday, August 9, 2019, both days inclusive, for determining the eligibility of shareholders for payment of Dividend.
23-05-2019
Bigul

Annual report for Novartis India Ltd. for FY-2019
23-05-2019
Next Page
Close

Let's Open Free Demat Account